Atavistik Bio Announces Collaboration with Plex Research to Enrich the Informatics Capabilities of its AMPS Platform and Accelerate the Discovery of Novel Small Molecule Therapeutics Portfolio News / By Karina Tin January 10, 2023
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones Portfolio News / By Karina Tin January 9, 2023
NGM Bio Outlines Corporate Strategy and Provides Guidance on Key Priorities Portfolio News / By Karina Tin January 9, 2023
Tenaya Therapeutics Announces TN-201 IND Clearance and Anticipated 2023 Milestones Portfolio News / By Karina Tin January 9, 2023
Nurix Therapeutics Advances Promising Targeted Protein Modulation Pipeline and Outlines 2023 Strategic Priorities Portfolio News / By Karina Tin January 9, 2023
Synthekine Secures $100 Million Series C Financing to Advance Pipeline of Engineered Cytokine Therapeutics Portfolio News / By Karina Tin January 6, 2023
Carmot Therapeutics Launches Spin-Off, Kimia Therapeutics, to Focus on Metabolic Disease Portfolio News / By Karina Tin January 5, 2023
eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin and General Corporate Update Portfolio News / By Karina Tin January 5, 2023
Remix Therapeutics Appoints Christopher Bowden, M.D., as Chief Medical Officer Portfolio News / By Karina Tin January 5, 2023
ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer Portfolio News / By Karina Tin December 21, 2022
